The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled ...
Dec 20, 2022
0
29
Drug manufacturers and the Food and Drug Administration (FDA) scrambled earlier this month to address a sudden shortage of methotrexate, a 60-year-old drug that treats children with severe cases of leukemia and sarcoma. Graham ...
Feb 28, 2012
0
0
Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer. In a new benefit assessment, the German Institute ...
Aug 2, 2013
0
0
Germany will pay up to 50 percent more for common children's medication such as cough syrup and fever drugs to combat a severe shortage this winter, the health minister said Tuesday.
Dec 20, 2022
0
1
With Boris Johnson as prime minister, a no-deal Brexit looks more likely. Indeed, Goldman Sachs recently raised the probability of a no-deal Brexit from 15% to 20%. Faced with an uncertain future, it is difficult to make ...
Aug 1, 2019
0
7
The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers.
Apr 1, 2013
0
0
The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies ...
Mar 25, 2015
0
5
Consumer-friendly ratings of the benefits of new drugs. Limits on what patients pay. Requiring drug companies to disclose how much they actually spend on research.
Sep 18, 2015
0
6
Scientists have developed a new approach to produce life-saving oligonucleotide therapeutics on a large scale, in high purity, and with minimal environmental impacts. The finding, by The University of Manchester, will facilitate ...
Jun 28, 2023
0
8
One of the largest makers of generic opioids has settled a lawsuit with two Ohio counties, removing the company from the first federal trial over the toll of the opioid crisis.
Sep 6, 2019
0
5
